GlassScriptPhysician profile
Breanna L Farmer
NPI 1548893548
$2,009.12
in general payments reported to CMS, 2019-2025
30 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $219 · 2022: $495 · 2023: $456 · 2024: $489 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $799.20 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $170.94 | 2021-2024 | Gattex, Eohilia |
| Daiichi Sankyo INC. | $119.88 | 2021-2023 | Injectafer |
| Nestle Healthcare Nutrition INC. | $108.09 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $97.69 | 2022-2024 | Dificid |
| Regeneron Healthcare Solutions, INC. | $87.12 | 2022-2024 | Dupixent |
| Janssen Biotech, INC. | $67.60 | 2022-2023 | Simponi Aria, Stelara, Simponi |
| Boston Scientific Corporation | $59.52 | 2023-2025 | Contour Vl, Watchman Access System |
| Urovant Sciences INC | $50.45 | 2022 | |
| Lilly USA, LLC | $35.73 | 2024 | Omvoh |
| Intercept Pharmaceuticals, INC. | $34.50 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.04 | 2021-2022 | |
| Medtronic, INC. | $29.82 | 2021 | |
| Urogen Pharma, INC. | $28.59 | 2025 | |
| Polynovo North America LLC | $28.29 | 2024 | Novosorb Btm |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $27.90 | 2024 | Andexxa |
| Madrigal Pharmaceuticals | $24.15 | 2025 | Rezdiffra |
| Endo USA, INC. | $23.41 | 2024 | Xiaflex |
| Phathom Pharmaceuticals, INC. | $20.18 | 2024 | Voquezna |
| Progenics Pharmaceuticals, INC. | $17.82 | 2025 | |
| Teleflex LLC | $17.04 | 2023 | Quikclot |
| Redhill Biopharma INC. | $16.24 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.88 | 2025 | Jardiance |
| Sumitomo Pharma America, INC. | $15.14 | 2023 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $15.03 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.95 | 2023 | |
| Paratek Pharmaceuticals, INC. | $13.29 | 2022 | |
| Dentsply Ih Ab | $13.22 | 2023 | Lofric |
| Edwards Lifesciences Corporation | $13.13 | 2023 | Hemosphere |
| Vivus LLC | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breanna Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.